Bone Biologics Corp (NASDAQ: BBLG) shares are trading lower by 12% to $0.54 Monday morning on downward momentum after the company last week announced it's conducting a public offering and private placement to sell over a million shares of its common stock at $0.64 each, alongside unregist
Bone Biologics Corp (NASDAQ: BBLG) shares are trading lower by 38% to $0.48 Friday morning after the company announced it's conducting a public offering and private placement to sell over a million shares of its common stock at $0.64 each, alongside unregistered warrants to purchase
Turnstone Biologics (NASDAQ:TSBX – Get Free Report) and Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Analyst Recommendations This is a breakdown of […]
Item 2.02 Results of Operations and Financial Condition.
To the extent applicable to this Item, the disclosure set forth in Item 8.01 is
incorporated by reference herein.
Item 5.02 Departure of. | January 4, 2023
IRW-News: MustGrow Biologics Corp.: MustGrow Biologics erhöht Privatplatzierung auf 6,9 Mio. CAD - Gluskin investiert 1 Mio. CAD () aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.